All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
OLEMA PHARMACEUTICALS, INC. Last Reported: 4/30/2024 Stock Symbol: OLMA

Business Address

780 BRANNAN STREET

SAN FRANCISCO , CA US 94103

Mailing Address

780 BRANNAN STREET

SAN FRANCISCO , CA US 94103
Phone Number: (415) 651-3316 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 11/30/2020 6/30/2020 3/31/2020 12/31/2019 12/31/2018
Cash and Cash Equivalents $33,720,000.00 $68,539,000.00 $117,407,000.00 $34,958,000.00 $40,918,000.00 $23,702,000.00 $26,804,000.00 $24,526,000.00 $21,509,000.00 $13,812,000.00 $25,597,000.00 $50,422,000.00 $47,881,000.00 $338,549,000.00 -- -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $3,113,000.00 $4,706,000.00 $5,107,000.00 $4,065,000.00 $3,443,000.00 $4,478,000.00 $2,458,000.00 $2,315,000.00 $2,347,000.00 $3,435,000.00 $2,326,000.00 $2,710,000.00 $3,297,000.00 $3,588,000.00 -- -- -- -- --
Total Current Assets $252,090,000.00 $266,513,000.00 $282,008,000.00 $171,509,000.00 $189,397,000.00 $208,899,000.00 $225,058,000.00 $243,026,000.00 $270,214,000.00 $290,685,000.00 $308,280,000.00 $320,854,000.00 $330,265,000.00 $342,137,000.00 -- -- -- -- --
Property Plant and Equipement $1,033,000.00 $968,000.00 $1,056,000.00 $1,273,000.00 $1,380,000.00 $1,480,000.00 $1,404,000.00 $1,450,000.00 $1,420,000.00 $1,474,000.00 $975,000.00 $866,000.00 $526,000.00 $75,000.00 -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- $2,771,000.00 $2,771,000.00 $2,771,000.00 $3,096,000.00 $2,794,000.00 $540,000.00 $540,000.00 $510,000.00 $510,000.00 $510,000.00 -- -- -- -- --
Total Assets $263,694,000.00 $276,945,000.00 $292,799,000.00 $177,624,000.00 $195,768,000.00 $215,645,000.00 $231,997,000.00 $250,600,000.00 $277,418,000.00 $295,945,000.00 $309,795,000.00 $322,230,000.00 $331,301,000.00 $342,722,000.00 -- -- -- -- --
Accounts Payable $7,656,000.00 $2,698,000.00 $2,207,000.00 $1,625,000.00 $681,000.00 $374,000.00 $14,000.00 $120,000.00 $268,000.00 $23,000.00 $306,000.00 $385,000.00 $419,000.00 $719,000.00 -- -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $27,376,000.00 $23,050,000.00 $17,665,000.00 $16,041,000.00 $20,793,000.00 $18,099,000.00 $14,298,000.00 $14,317,000.00 $12,328,000.00 $11,377,000.00 $8,901,000.00 $8,146,000.00 $5,277,000.00 $4,585,000.00 -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-10,000.00 $347,000.00 $-241,000.00 $-518,000.00 $-978,000.00 $-1,813,000.00 $-2,674,000.00 $-2,398,000.00 $-1,626,000.00 $-149,000.00 $15,000.00 $-14,000.00 $-13,000.00 -- -- -- -- -- --
Accumulated Deficit $-336,602,000.00 $-305,632,000.00 $-278,860,000.00 $-257,358,000.00 $-237,263,000.00 $-208,977,000.00 $-182,798,000.00 $-160,078,000.00 $-127,220,000.00 $-104,190,000.00 $-82,552,000.00 $-64,839,000.00 $-48,433,000.00 $-33,094,000.00 -- -- -- -- --
Total Stockholders' Equity $236,318,000.00 $253,895,000.00 $275,134,000.00 $161,583,000.00 $174,975,000.00 $197,546,000.00 $217,699,000.00 $236,283,000.00 $265,090,000.00 $284,568,000.00 $300,894,000.00 $314,084,000.00 $326,024,000.00 $338,137,000.00 -- $-13,952,000.00 $-11,653,000.00 $-10,594,000.00 $-8,397,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $263,694,000.00 $276,945,000.00 $292,799,000.00 $177,624,000.00 $195,768,000.00 $215,645,000.00 $231,997,000.00 $250,600,000.00 $277,418,000.00 $295,945,000.00 $309,795,000.00 $322,230,000.00 $331,301,000.00 $342,722,000.00 -- -- -- -- --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 11/30/2020 6/30/2020 3/31/2020 12/31/2019 12/31/2018
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $29,883,000.00 $86,140,000.00 $60,268,000.00 $40,815,000.00 $22,826,000.00 $82,274,000.00 $60,690,000.00 $27,054,000.00 $16,009,000.00 $51,100,000.00 $35,125,000.00 $22,602,000.00 $10,692,000.00 -- -- $2,742,000.00 $795,000.00 -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $34,339,000.00 $104,961,000.00 $74,545,000.00 $51,203,000.00 $29,602,000.00 $106,988,000.00 $23,222,000.00 $33,293,000.00 $23,254,000.00 $71,491,000.00 $49,734,000.00 $31,972,000.00 $15,450,000.00 -- -- $3,529,000.00 $1,043,000.00 -- --
Loss from Operations $-34,339,000.00 $-104,961,000.00 $-74,545,000.00 $-51,203,000.00 $-29,602,000.00 $-106,988,000.00 $-79,769,000.00 $-33,293,000.00 $-23,254,000.00 $-71,491,000.00 $-17,762,000.00 $-31,972,000.00 $-15,450,000.00 -- -- $-3,529,000.00 $-1,043,000.00 -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.56 $-2.14 $-0.48 $-0.49 $-0.70 $-2.62 $-0.57 $-0.82 $-0.58 $-1.80 $-1.25 $-0.81 -- -- -- $-0.95 -- -- --
Weighted Average Shares Basic 55,574,324 45,247,098 41,999,978 40,720,294 40,354,493 39,995,460 40,036,201 39,876,650 39,834,619 39,524,272 39,450,655 39,370,809 -- -- -- 2,593,316 -- -- --
Earnings Per Share Diluted $-0.56 $-2.14 $-1.66 $-1.20 $-0.69 $-2.62 $-1.97 $-1.40 $-0.58 $-1.80 $-0.45 $-0.81 -- -- -- $-0.95 -- -- --
Weighted Average Shares Diluted 55,574,324 45,247,098 44,977,161 40,720,294 40,354,493 39,995,460 40,036,201 39,876,650 39,834,619 39,524,272 39,450,655 39,370,809 -- -- -- 2,593,316 -- -- --
Common Stock Shares Authorized 490,000,000 490,000,000 490,000,000 490,000,000 490,000,000 490,000,000 490,000,000 490,000,000 490,000,000 490,000,000 490,000,000 490,000,000 490,000,000 490,000,000 490,000,000 -- -- -- --
Common Stock Shares Outstanding 55,867,863 54,992,784 54,601,516 41,122,482 40,438,320 40,287,097 40,084,568 39,974,459 39,869,325 39,797,263 39,681,298 39,552,588 39,342,129 39,308,238 -- -- -- -- --
Common Stock Value $4,000.00 $4,000.00 $4,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com